BIT
TENX icon

BlackRock Institutional Trust’s Tenax Therapeutics TENX Stock Holding History

BlackRock Institutional Trust’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1
Closed -$66K – 3886
2016
Q3 		$66K Hold
1
– – ﹤0.01% 3728
2016
Q2 		$81K Hold
1
– – ﹤0.01% 3732
2016
Q1 		$65K Hold
1
– – ﹤0.01% 3766
2015
Q4 		$104K Hold
1
– – ﹤0.01% 3743
2015
Q3 		$95K Hold
1
– – ﹤0.01% 3739
2015
Q2 		$117K Hold
1
– – ﹤0.01% 3705
2015
Q1 		$104K Hold
1
– – ﹤0.01% 3703
2014
Q4 		$122K Hold
1
– – ﹤0.01% 3697
2014
Q3 		$125K Hold
1
– – ﹤0.01% 3660
2014
Q2 		$142K Buy
+1
New +$154K ﹤0.01% 3738

Other funds holding TENX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock Institutional Trust's TENX Position: Q4 2016 in Review

BlackRock Institutional Trust sold out of Tenax Therapeutics (TENX) in Q4 2016, closing a stake of 1 share — an estimated $66K sold.

BlackRock Institutional Trust first reported a position in TENX in Q2 2014 and held it in 10 quarters. The position peaked at $142K in Q2 2014. 19 funds tracked by Wall St. Rank hold TENX as of Q4 2016.

  • BlackRock Institutional Trust reported no remaining Tenax Therapeutics position as of Q4 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 1 Tenax Therapeutics share in Q4 2016, an estimated $66K.
  • BlackRock Institutional Trust first reported a position in Tenax Therapeutics in Q2 2014 and held it in 10 quarters.
  • BlackRock Institutional Trust's Tenax Therapeutics position peaked at $142K in Q2 2014.
  • 19 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.